For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Endologix, Inc.

USPTO Granted Patents = 91

EPO Patents = 26

Trademarks = 16

Forward Citations = 2,804

Loading Chart...

Loading Chart...

80 inventors (with patents filed for the assignee):

Stefan G Schreck (35 out of 74 patents)

Samuel M Shaolian (16 out of 107 patents)

Gilbert Madrid (14 out of 25 patents)

4. Trinh Van Pham (14 out of 16 patents)

5. Joshua Benjamin (13 out of 14 patents)

6. Kevin Mayberry (11 out of 11 patents)

7. Craig Welk (11 out of 20 patents)

8. Myles S Douglas (9 out of 14 patents)

9. Thanh Van Nguyen (8 out of 80 patents)

10. Kevin Chu (7 out of 8 patents)

11. Charles Bankert (6 out of 12 patents)

12. Paolo Mendoza (6 out of 6 patents)

13. To Van Pham (6 out of 28 patents)

14. Jacqueline Macias (5 out of 9 patents)

15. Amy Catherine Lee (5 out of 34 patents)

Core Competencies:

Endoluminal Devices

Catheter Systems

Stent Graft Systems

Aneurysm Treatment

Hydrogels

Inflatable Fill Structures

Vascular Dissections

Fenestrated Prosthesis

Graft Systems

Modular Stent Grafts

Inflammatory Response Modulation

Percutaneous Methods

91 patents: Sort by Forward Citations

1. 12508118 - Stent graft systems with restraints in channels and methods thereof (2025-12-30),

2. 12350142 - Systems and methods with graft body, inflatable fill channel, and filling structure (2025-07-08),

3. 12240973 - Endoluminal device and polymer (2025-03-04),

4. 12239558 - Catheter system and methods of using same (2025-03-04),

5. 12186215 - Locking assembly for coupling guidewire to delivery system (2025-01-07),

6. 12070400 - Endoluminal prosthesis systems and methods (2024-08-27),

7. 11938284 - Catheter system and methods of using same (2024-03-26),

8. 11786252 - Method and system for treating aneurysms (2023-10-17),

9. 11759553 - Method for forming hydrogels and materials therefor (2023-09-19),

10. 11723668 - Systems and methods with anchor device for fixation of filling structures in blood vessels (2023-08-15),

11. 11717392 - Modulation of inflammatory response following endovascular treatment (2023-08-08),

12. 11660179 - Stent graft systems with restraints in channels and methods thereof (2023-05-30),

13. 11638638 - Filling structure for a graft system and methods of use (2023-05-02),

14. 11596413 - Methods and systems for aneurysm treatment using filling structures (2023-03-07),

15. 11571291 - Percutaneous method and device to treat dissections (2023-02-07),

Endologix, Inc. is a medical device company that develops, manufactures, and sells innovative endovascular treatments for aortic disorders. Their mission is to provide minimally invasive solutions to improve the quality of life for patients suffering from vascular diseases. Endologix offers a wide range of products and technologies, including endovascular stent grafts, catheters, and accessories, designed to treat abdominal aortic aneurysm (AAA) and other vascular conditions. Through constant innovation and collaboration with healthcare professionals, Endologix aims to advance the field of endovascular therapy and provide effective, life-saving treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

91 Patents

#36 in Irvine, CA

#950 in California

#3,961 in US

#8,185 in the World

Irvine, CA, United States of America

Endologix, Inc.

Forward Citations = 2,804

80 inventors:

Stefan G Schreck (35 out of 74 patents)

Samuel M Shaolian (16 out of 107 patents)

Gilbert Madrid (14 out of 25 patents)

4. Trinh Van Pham (14 out of 16 patents)

5. Joshua Benjamin (13 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…